Medicago reports promising but preliminary results of possible COVID-19 vaccine

Canadian drug developer Medicago says a combination of its experimental COVID-19 vaccine and GlaxoSmithKline's vaccine booster produced an antibody response in a Phase 1 clinical trial.

source https://www.cbc.ca/news/health/medicago-covid-19-vaccine-phase-1-1.5796411?cmp=rss